the previous year. Exclusion criteria were: (1) use of any fluoride or bisphosphonates; (2) illness or prescriptions influencing bone metabolism; (3) current (or over past 6 months) utilization of estrogen or calcitonin; (4) a history of endometrial or breast cancer; (5) any bone fracture; and (6) regular physical exercise or sensitivity to Fennel (Foeniculum vulgare Mill.). In the following stage, participants signed an informed consent form alongside verbal assurance about voluntary nature of the study and that they could drop out of the study at will. Moreover, assurance was given to participants regarding the confidentiality of data during and after the study. At the baseline, 60 subjects were randomized to fennel or placebo group. Participants were expected to take soft capsule three times a day -(morning, noon and night). Each 100-mg fennel capsule contained a combination of 30% fennel (Standardized to 21-27 mg anethole) and sunflower oil. Active elements of each capsule were Transanthol, Methyl chavicol, fenechon and stragol.
Placebos were similar in shape and size but filled with sunflower oil. These capsules were the courtesy of Barij Essence Company. The distribution was on the basis of an arbitrary number table. That is, to ensure the concealment of allocation, a numbered, sealed and non-transparent plastic bottle was used, which contained sufficient capsules for 30 days. An employee of Barij Essence Pharmaceutical Company, who was not directly involved in the study, was in charge of allocation sequencing and packing. Also, both subjects and research group were blind to the treatment. 
Laboratory methods

Statistical tests
Kolmogorov-Smirnov test was used to test whether samples had a normal distribution. Paired t-tests (within group) was used to compare between the baseline and three-month period, and Student's t-test was used to compare between treatment groups. Statistical tests were two-sided, and a Pvalue < 0.05 was considered statistically significant.
Results
The two groups were similar in variables such as age, history of hysterectomy, body weight, body mass index, and duration of menopause at the baseline, as shown in Table 1 .
Side effects were observed in 6 subjects in the fennel group and 3 subjects in the placebo group. In the fennel group, subjects complained of allergic rash (n = 1), weight gain (n = 1), hypertension (n = 1) and vaginal bleeding (n = 2). Only one patient in placebo group complained of stomachache. Table 2 showed the lipid levels at baseline and after three treatments. There was no significant difference in profiles lipids triglyceride (P = 0.679), total cholesterol (P = 0.103), LDL concentrations (P = 0.104) and HDL (P = 0.266) between groups. Also, in both group, Paired t-test showed no significant difference in all mentioned parameters except HDL-C that showed a significant borderline improvement (P = 0.052) in the fennel group. 
Discussion
To the best of our knowledge, this is the first study to assess the effects of fennel on lipid the profiles among the postmenopausal women. According to the results of this study, the group treated with fennel showed a very slight positive change in LDL-C and triglyceride. Moreover improved HDL concentration reached the borderline level of statistical significance (P = 0.052) after three months. However, no significant difference was found between the two groups on the lipid parameters.
As we know, there is no human study on the fennel effectiveness of on the lipid profiles. Nevertheless, considering that phytoestrogen is an active biological compound in fennel, we referred to studies evaluating the effects of phytoestrogen on the lipid profiles. The phytoestrogens are plant compounds with properties similar to the estrogen.
The major types of phytoestrogens are isoflavones, lignans, flavonoids and coumestans. 12 Soy and red clover have high content of isoflavones. 4 Lignans are mainly found in flaxseed 13 and fennel is a rich source of flavonoids. 8 Hallund et al. 14 The data is presented as mean ± standard deviation or n (%) J MM made hyperlipidemia for 6 weeks. The rats in the Group 6 was made hyperlipidemia for 3 weeks and then treated with fennel for 6 weeks. When comparing with the control group, the Groups 4 and 6 showed higher significant decrease (P < 0.01) in levels of liver total lipids. They concluded that the fennel might shift liver total lipid value to normal level. The possible mechanism of action of the fennel on reducing lipids could be attributed to its anti-oxidative properties and radical scavenging activity. 10 Fatiha et al. 16 performed the second research on 18 rats with the mean weight of 20 ± 2 g divided into three group of six. The Group 1 (control) received intraperitoneal normal saline and water via gavages.
The Group 2 was made hyperlipidemia by Triton WR-1339.
In the Group 3, the rats was made hyperlipidemia by WR-1339, and then treated with the fennel. The blood samples were collected after scarifying the rats. Then, the samples were immediately centrifuged to separate the plasma for analyzing the lipid parameters (total cholesterol, HDL-C),
and LDL-C, triglycerides, apolipoproteins. The second group showed 35%, 50% and 50% decrease in the total cholesterol, triglycerides and LDL-C, respectively. They concluded that administration of methanol extract of fennel might have anti-atherosclerotic and hyperlipidemic effects.
Conclusion
There were several limitations in our study. First, the sample size was relatively small and the research units were followed-up only for three month. Seconded limitation of the current study was its failure to control the lifestyle habits, like physical activity and diet. However, the subjects were requested not to change their routine diet and physical activity over the study period. Third, we did not calculate the inter-and intra-assay coefficients.
The fennel revealed a very slight positive change in the LDL-C, triglyceride, and HDL concentrations. Further studies with longer durations, higher doses, and larger sample sizes are required to validate the results of this study.
